Austar Lifesciences Ltd. (HK:6118) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Austar Lifesciences Ltd. has completed the acquisition of a 51% equity interest in a target company for $1.515 million, making it a wholly-owned subsidiary. This strategic move is aimed at enhancing market competitiveness and operational efficiency, as well as reducing costs by integrating resources within the group. The acquisition is expected to bolster Austar’s financial performance by leveraging the existing partnership with STERIS.
For further insights into HK:6118 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue